XML 44 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Income Tax Provision (Tables)
12 Months Ended
Jun. 30, 2024
Income Tax Provision  
Schedule of income tax expense differed from the amounts computed by applying the U.S. federal income tax rate

The income tax expense for the years ended June 30, 2024 and 2023 differed from the amounts computed by applying the U.S. federal income tax rate of 21% and 21% respectively as follows:

For the Year Ended

 

    

June 30, 

    

June 30, 

 

2024

2023

 

Federal statutory rate

 

(21.00)

%  

(21.00)

%

Research and development credit

 

3.45

%  

1.10

%

State tax rate

 

(5.93)

%  

(5.93)

%

Other

 

(0.95)

%  

(0.65)

%

Valuation allowance

 

24.43

%  

26.48

%

Effective tax rate

 

 

Schedule of components of the Company's deferred tax assets

The significant components of the Company’s deferred tax assets at June 30, 2024 and 2023 are as follows:

    

June 30, 

    

June 30, 

2024

2023

Net operating loss

$

29,351,534

$

27,960,157

Research and development credit

 

8,154,686

 

7,868,816

IRC Sec.174 R&E capitalization

 

2,243,662

 

1,536,679

Other

 

22,087

 

25,194

Total gross deferred tax assets

 

39,771,969

 

37,390,846

Less: valuation allowance

 

(39,771,969)

 

(37,390,846)

Net deferred tax asset

$

$